Weight-loss drugs can cut future health costs. The fight is over who pays now.

Millions of Americans who could benefit from GLP-1 weight-loss drugs are caught in the middle of a battle between drug companies and insurers over their costs, leaving them without coverage even as evidence mounts that the drugs could stave off expensive health complications in the future. Subscribe for unlimited access to The Post You can cancel anytime. Subscribe